PDZ Domain Containing 9 (PDZD9) (Middle Region) Peptide
PDZD9
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all PDZD9 products
- PDZD9 (PDZ Domain Containing 9 (PDZD9))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-C16orf65 antibody (Catalog #: ARP55697_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDZD9 (PDZ Domain Containing 9 (PDZD9))
- Synonyms
- C16orf65 Peptide, C25H16orf65 Peptide, 4930408O21Rik Peptide, LRRGT00105 Peptide, PDZ domain containing 9 Peptide, PDZD9 Peptide, Pdzd9 Peptide
- Background
-
The specific function of the protein remains unknown.
Alias Symbols: MGC50721, C16orf65
Protein Size: 202 - Molecular Weight
- 23 kDa
- Gene ID
- 255762
- NCBI Accession
- NM_173806, NP_776167
- UniProt
- Q8IXQ8
-
You are here:
